Liver cancer wars: plant-derived polyphenols strike back

Department

Internal Medicine

Additional Department

Gastroenterology

Document Type

Article

Publication Title

Medical Oncology (Northwood, London, England)

Abstract

Liver cancer currently represents the leading cause of cancer-related death worldwide. The majority of liver cancer arises in the context of chronic inflammation and cirrhosis. Surgery, radiation therapy, and chemotherapy have been the guideline-recommended treatment options for decades. Despite enormous advances in the field of liver cancer therapy, an effective cure is yet to be found. Plant-derived polyphenols constitute a large family of phytochemicals, with pleiotropic effects and little toxicity. They can drive cellular events and modify multiple signaling pathways which involves initiation, progression and metastasis of liver cancer and play an important role in contributing to anti-liver cancer drug development. The potential of plant-derived polyphenols for treating liver cancer has gained attention from research clinicians and pharmaceutical scientists worldwide in the last decades. This review overviews hepatic carcinogenesis and briefly discusses anti-liver cancer mechanisms associated with plant-derived polyphenols, specifically involving cell proliferation, apoptosis, autophagy, angiogenesis, oxidative stress, inflammation, and metastasis. We focus on plant-derived polyphenols with experiment-based chemopreventive and chemotherapeutic properties against liver cancer and generalize their basic molecular mechanisms of action. We also discuss potential opportunities and challenges in translating plant-derived polyphenols from preclinical success into clinical applications.

First Page

116

DOI

10.1007/s12032-024-02353-1

Volume

41

Issue

5

Publication Date

4-16-2024

Medical Subject Headings

Humans; Polyphenols (pharmacology, therapeutic use); Liver Neoplasms (drug therapy); Apoptosis; Inflammation

PubMed ID

38625672

Link to Full Text

Share

COinS